FAKTOR-OPTIONSSCHEIN - INCYTE CO. Share Price

DE000SD416S6

Market Closed - Bid/Ask 20:20:20 23/05/2024 BST			After market 20:35:52
2.45 ^EUR	+3.38%		2.465	+0.61%

Current month	-51.30%
1 month	-51.30%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target	05:47pm	MT
Incyte Acquires 2 Office Buildings in Delaware	05-21	MT
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings	05-21	BU
Incyte to Present at Upcoming Investor Conference	05-21	BU

More news

Quotes 5-day view

Date	Price	Change
23/05/24	2.45	+3.38%
22/05/24	2.37	-5.58%
21/05/24	2.51	-3.09%
20/05/24	2.59	+1.17%
17/05/24	2.56	-2.66%

Real-time Boerse Frankfurt Warrants

Last update May 23, 2024 at 08:20 pm

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Société Générale
WKN	SD416S
ISIN	DE000SD416S6
Date issued	29/03/2021
Strike	79.94 $
Maturity	Unlimited
Parity	1 : 1
Emission price	8.47 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	17.82 €
Lowest since issue	0.91 €
Spread	0.01 €
Spread %	0.41%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

58.2 USD

Average target price

72.8 USD

Spread / Average Target

+25.09%

Consensus